Location History:
- Montreal, CA (2015)
- West Point, PA (US) (2016)
- Rahway, NJ (US) (2017)
- Colonia, NJ (US) (2015 - 2024)
Company Filing History:
Years Active: 2015-2024
Title: Innovations and Contributions of Inventor Carmela Molinaro
Introduction
Carmela Molinaro, an accomplished inventor based in Colonia, New Jersey, has made significant contributions to the field of biochemistry through her innovative research and inventions. With a remarkable portfolio of ten patents, her work focuses on engineered polypeptides with imine and oxime reductase activities, paving the way for advancements in chemical processes.
Latest Patents
Among her latest patents is the development of engineered imine reductases aimed at improving the reductive amination of ketone and amine compounds. This patent presents engineered polypeptides that exhibit imine or oxime reductase activity. It includes polynucleotides encoding these engineered polypeptides, as well as host cells capable of expressing them. This groundbreaking work provides methods for utilizing these engineered polypeptides with various ketone and amine substrate compounds, leading to the synthesis of valuable secondary and tertiary amine products.
Career Highlights
Carmela has demonstrated her expertise in the industry through her tenure at notable companies such as Merck Sharp & Dohme Corporation and Merck Canada Inc. Her roles within these prestigious firms have contributed to her understanding of biochemical applications and innovations, further establishing her as a leading figure in her field.
Collaborations
Throughout her career, Carmela Molinaro has collaborated with respected colleagues, including Christian Beaulieu and David Jonathan Bennett. These partnerships have fostered an environment of shared knowledge and expertise, resulting in increased innovation and the successful development of several patented technologies.
Conclusion
Carmela Molinaro's work exemplifies the essence of innovation and the impact that a dedicated inventor can have on the scientific community. Her continued development of novel engineered polypeptides promises to advance the methodologies in biochemical synthesis, showcasing the importance of her contributions to the industry. As she progresses in her career, the potential for future breakthroughs remains high.